Found 8 matching trials
A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine PHASE3 The purpose of this study is to learn about the safety effects of the Lyme ...
Show More Location
Northern Light Eastern Maine Medical Center
Learn More & Join Trial
Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children PHASE3 This study is to understand if the study vaccine (called VLA15) is safe in ...
Show More Location
UAB Child Health Research Unit (CHRU)
Learn More & Join Trial
An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15) PHASE3 The main purpose of this clinical study is to evaluate a 6-valent OspA-base...
Show More Location
Care Access - Essex
Learn More & Join Trial
Study Assessing the Safety, Immunogenicity and Dose Response of VLA15, A New Vaccine Candidate Against Lyme Borreliosis PHASE1 Observer-blind, partially randomized, multi-center dose escalation Phase I ...
Show More Learn More & Join Trial
Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study. PHASE2 This is a randomized, observer-blind, placebo controlled, multicenter Phase...
Show More Location
Clinical Research Consulting, LLC
Learn More & Join Trial
A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults PHASE3 The purpose of this study is to learn about the safety and effects of the L...
Show More Status
Active Not Recruiting
Location
IMA Clinical Research Warren
Learn More & Join Trial
Alternative Schedule Study For VLA15, a Vaccine Candidate Against Lyme Borreliosis PHASE2 In the Main Study Phase a total of 246 subjects were randomized 2:2:1 into ...
Show More Location
Clinical Research Consulting, LLC
Learn More & Join Trial
Phase 2 Study Of VLA15, A Vaccine Candidate Against Lyme Borreliosis, In A Healthy Pediatric And Adult Study Population PHASE2 VLA15-221 is a Phase 2 study, which will be conducted in two parts: Main St...
Show More Location
New England Research Associates
Learn More & Join Trial